Synthesis, In-Vitro and In-Silico Studies of Benzothiazole Azo-Ester Derivatives as Anti-TB Agents

Author(s): Mahesh Bhat*, Shiddappa L. Belagali.

Journal Name: Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry

Volume 18 , Issue 1 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Introduction: A new series of benzothiazole azo-ester derivatives was synthesized by using Steglish esterification reaction.

Methods: All the synthesized compounds were screened for their anti-TB activities by in vitro microplate Alamar Blue assay method against M. tuberculosis (H37RV strain). All the compounds showed activities and their MIC values were over the range of 1.6 µg/mL to 50 µg/mL. The compounds 4d and 4j showed superior activity with MIC 1.6 µg/mL compared to the standard drug Streptomycin (MIC 6.25 µg/mL), Pyrazinamide (MIC 3.125 µg/mL) and Ciprofloxacin (MIC 3.125 µg/mL).

Results: Molecular docking study was carried out with enoyl acyl carrier reductase (InhA) of M. tuberculosis and decaprenyl phosphoryl-D-ribose oxidase (DprE1).

Conclusion: These studies showed that these compounds have more interaction with InhA protein whereas some compounds could not be docked into DprE1.

Keywords: Azo-ester, anti-TB, molecular docking, esterification, ciprofloxacin, steglish esterification reaction.

[1]
Hameed, S.A. Characterization and thermal decomposition of indolylidene aniline azo-dyes derivatives. Jordan J. Chem., 2007, 2, 133-144.
[2]
Thaker, B.T.; Patel, B.S.; Dhimmar, Y.T.; Chothani, N.J.; Solanki, D.B.; Patel, N.; Patel, K.B.; Makawana, U. Mesomorphic studies of novel azomesogens having a benzothiazole core: synthesis and characterization. Liq. Cryst., 2013, 40(2), 237-248.
[http://dx.doi.org/10.1080/02678292.2012.737478]
[3]
Karim, M.R.; Yahya, R.; Karim Sheikh, M.R.; Salleh, N.M.; Hassan, A.; Ekramul Mahmud, H.N.M. Synthesis, thermal stability, optical and electrochemical properties of halogen terminated azobenzothiazole mesogen containing sematic side chain liquid crystalline polymers. J. Polym. Res., 2014, 21, 487-496.
[http://dx.doi.org/10.1007/s10965-014-0487-3]
[4]
Awale, A.G.; Gholse, S.B.; Utale, P.S. Synthesis, spectral properties and applications of some mordant and disperse mono azo dyes derived from 2-amino-1, 3-benzothiazole. Res. J. Chem. Sci., 2013, 3(10), 81-87.
[5]
Pavluchenko, A.I.; Smirnova, N.I.; Titov, V.V.; Kovahev, E.I.; Djumaev, K.M. Synthesis of new schiff base ester liquid crystals with a benzothiazole core. Mol. Cryst. Liq. Cryst. (Phila. Pa.), 1976, 37, 35-46.
[http://dx.doi.org/10.1080/15421407608084344]
[6]
Prajapati, A.K.; Bonde, N.L. Mesogenic benzothiazole derivatives with methoxy substituents. J. Chem. Sci., 2006, 118(2), 203-210.
[http://dx.doi.org/10.1007/BF02708475]
[7]
Yeap, G.Y.; Alshargabi, A.; Ito, M.M.; Mahmood, W.A.K.; Takeuchi, D. Synthesis and anisotropic properties of Azo-bridged benzothiazole-phenyl esters. Mol. Cryst. Liq. Cryst. (Phila. Pa.), 2012, 557, 126-133.
[http://dx.doi.org/10.1080/15421406.2011.637744]
[8]
Otera, J. Esterification Methods. Reactions and Applications; Wiley-VCH: Weinheim, Germany, 2003.
[9]
Larock, R.C. Comprehensive Organic Transformations, 2nd ed; Wiley & Sons: New York, 1999.
[10]
Bhat, M.; Belagali, S.L. Synthesis of azo-bridged benzothia-zole-phenyl ester derivatives via steglich esterification. Int. J. Cur. Eng. Tech., 2014, 4(4), 2711.
[11]
Bhat, M.; Belagali, S.L.; Madan, K.; Byrappa, K. Synthesis, characterization and crystal structure of 4-[(6-ethoxy benzothiazol-2-yl) diazenyl] phenyl 2-(2, 3-dihydro-1H-inden-2-yl) acetate. Chemical Data Collections, 2016, 7-8, 1-7.
[http://dx.doi.org/10.1016/j.cdc.2016.12.001]
[12]
Zerong, W. Steglich Catalyst; John Wiley & Sons Inc, 2010.
[13]
Christian, A.G.N.; Montalbetti, V.F. Amide bond formation and peptide coupling. Tetrahedron, 2005, 61, 10827-10852.
[http://dx.doi.org/10.1016/j.tet.2005.08.031]
[14]
Maria Lourenco, C.S.; deSouza Marcus, V.N.; Pinheiro, A.C.; Ferreira, M.L.; Rasnisb, B.G.; Thais, C.; Nogneira, M.; Monica, A.P. Evaluation of anti-Tubercular activity of nicotinic and isoniazid analogues. ARKIVOC, 2007, 15, 181-191.
[15]
Fathimunnisa, M.; Manikandan, H.; Neelakandan, K. Rajen-dra Prasad, N.; Selvanayagam, S.; Sridhar, B. Synthesis, characterization, biological evaluation and docking studies of 2′-[(2″,4″-difluorobiphenyl-4-yl)carbonyl]-1′-aryl-1′,2′,5′,6′,7′,7a′-hexahydrospiro[indole-3,3′-pyrrolizin]-2(1H)-ones. J. Mol. Struct., 2016, 1122, 205-210.
[http://dx.doi.org/10.1016/j.molstruc.2016.06.012]
[16]
Bhat, M.; Ganavi, B.C.; Sagar, B.K.; Vijay Shekar, E. Sulfadi-azine Guanidyl derivatives: synthesis, characterization and docking studies for potential antituberculosis agents. Asian J. Chem., 2018, 30(9), 2141-2144.
[http://dx.doi.org/10.14233/ajchem.2018.21487]
[17]
Bhat, M.; Belagali, S.L. Synthesis, characterization and biological screening of pyrazole-conjugated benzothiazole analogs. Future Med. Chem., 2018, 10(1), 71-87.
[http://dx.doi.org/10.4155/fmc-2017-0138] [PMID: 29235357]
[18]
Bhat, M.; Belagali, S.L. Guanidinyl and amide conjugated Benzothiazoles as potential anti-tubercular agent and their cytotoxicity study. Antiinfect. Agents, 2018, 16(2), 121-128.
[19]
Marrakchi, H.; Lanéelle, G.; Quémard, A.K.; Inh, A. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology, 2000, 146(Pt 2), 289-296.
[http://dx.doi.org/10.1099/00221287-146-2-289] [PMID: 10708367]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 1
Year: 2020
Page: [15 - 23]
Pages: 9
DOI: 10.2174/2211352517666190126160534

Article Metrics

PDF: 20
HTML: 4